Archive for June, 2010

Anesthesiologist Sentenced on Health Care Fraud Charge

Anesthesiologist Sentenced on Health Care Fraud

Tags:

Bottled Water Everywhere: Keeping it Safe

Consumers drink billions of gallons of bottled water each year. Find out about FDA’s role in ensuring that bottled water products are safe.

Tags:

Featured

Lancaster Foods, LLC Voluntarily Recalls Fresh Spinach with Best Enjoyed By Dates of June 19 to June 27, 2010 Due to Possible Health Risk

Lancaster Foods, LLC is voluntarily recalling fresh Spinach with the Best Enjoyed By dates of 19 JUN 10 through 27 JUN 10 sold under the brand names Krisp-Pak, Lancaster Fresh, Giant, and America’s Choice because they could be contaminated with Listeria monocytogenes. The recall extends only to products with this Use-by Date or Product Code and sold in the following states: New Jersey, Delaware, Pennsylvania, Maryland, North Carolina, and Virginia…

Tags:

Featured

United Pet Group Voluntarily Recalls Pro-Pet Adult Daily Vitamin Supplement for Dogs Because of Possible Salmonella Health Risk

United Pet Group, Cincinnati, Ohio is voluntarily recalling all unexpired lots of its PRO-PET ADULT DAILY VITAMIN Supplement tablets for Dogs due to possible Salmonella contamination. The Food and Drug Administration is aware of this recall.

Tags:

Magic Power Coffee: Potentially Dangerous—Not Magical

Magic Power Coffee, an instant coffee marketed as a dietary supplement for sexual enhancement, can cause dangerously lower blood pressure.

Tags:

FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg from U.S. Market

Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product’s safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.

Tags:

Mylotarg (gemtuzumab ozogamicin): Market Withdrawal

Drug failed to demonstrate clinical benefit to patients enrolled in trials.

Tags:

FDA to Hold Daylong Meeting on Medical Device Innovation

Each day, medical devices from renal dialysis machines to implantable defibrillators, help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.

Tags:

FDA Marks First Anniversary of Tobacco Control Act

One year ago, President Obama signed the historic Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act).

Tags:

Featured

Portland Shellfish Company Expands Recall to Include Meat Without Feet Label, Lobster Claw and Knuckle Meat, because of Possible Health Risk

Portland Shellfish Company, Inc. is expanding this voluntarily recall to include the Meat Without Feet private label food service (2 Lb bags), pack of ready to eat frozen lobster claw and knuckle meat. Lot 13310, as recent tests show the product has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems

Tags: